Overview
What is MIC / Lipo-C +?
MIC / Lipo-C + is a pre-mixed lipotropic solution built on the classic MIC base — methionine, inositol, and choline — with the additional B-vitamin and carnitine support components that characterize Lipo-C style formulations. Each constituent carries its own literature base in hepatic lipid handling, methyl-group donation, and mitochondrial fatty-acid transport. Supplied as a 10ml solution requiring no reconstitution.
MIC / Lipo-C + (Methionine · Inositol · Choline Lipotropic Blend) is supplied strictly as a reference material for in vitro and preclinical investigation. All characterization data described here is drawn from peer-reviewed literature and laboratory analysis; nothing herein constitutes a claim of clinical effect in humans.
Investigational Scope
Documented Research Areas
The following domains summarize directions explored across published studies and laboratory models. Each reflects observations reported in rodent models, in vitro systems, or the peer-reviewed record.
Hepatic Lipid Biology
Choline & Hepatic Fat Export
Choline-deficient diets are an established laboratory model of hepatic steatosis. Research has examined how choline availability governs phosphatidylcholine synthesis and the packaging of triglycerides for export from the liver.
Methylation
Methionine & the SAM Cycle
Methionine is the precursor to S-adenosylmethionine, the principal methyl donor in mammalian cells. Studies have examined how methionine availability affects transmethylation reactions and hepatic lipid metabolism in rodent models.
Insulin Signaling
Inositol & Phosphoinositide Pathways
Myo-inositol is the backbone of phosphoinositide second messengers involved in insulin signal transduction. Research has examined inositol supplementation in metabolic and insulin-sensitivity models.
Mitochondrial
Carnitine & Fatty-Acid Oxidation
Carnitine is required for transport of long-chain fatty acids into the mitochondrial matrix. Studies have documented its role as the rate-limiting element of the carnitine shuttle in β-oxidation research.
Proposed Mechanism
Mechanistic Pathway
Mechanistic steps below are hypothesized from in vitro assays and animal-model data reported in the literature. They describe biochemical interactions observed under controlled experimental conditions.
-
1
Phosphatidylcholine Synthesis
Choline feeds the CDP-choline pathway to phosphatidylcholine, a structural requirement for very-low-density lipoprotein assembly and the export of hepatic triglyceride in animal-model research.
-
2
Transmethylation via SAM
Methionine is adenylated to S-adenosylmethionine, which donates methyl groups across lipid, DNA, and protein methylation reactions before recycling through the homocysteine–methionine cycle.
-
3
Phosphoinositide Second Messengers
Inositol is incorporated into phosphatidylinositol species that generate IP3 and related messengers, linking receptor activation to intracellular calcium release and downstream metabolic signaling.
-
4
Carnitine Shuttle Transport
Carnitine palmitoyltransferase-1 conjugates long-chain acyl groups to carnitine at the outer mitochondrial membrane, permitting translocation into the matrix where β-oxidation proceeds.
Technical Data
Molecular Specifications
| Amino Acid Sequence | N/A — non-peptide small-molecule blend |
| Molecular Weight | Methionine 149.2 | Inositol 180.2 | Choline 104.2 g/mol |
| Molecular Formula | Blend — see individual components |
| CAS Number | 63-68-3 (methionine) · 87-89-8 (inositol) · 62-49-7 (choline) |
| Storage | 2–8°C refrigerated, protected from light. Do not freeze. |
References
Selected Literature
The following peer-reviewed references informed the research summaries on this page. Citations are provided for scientific context only.
- Zeisel SH & da Costa KA. (2009). Choline: an essential nutrient for public health. Nutrition Reviews, 67(11), 615–623.
- Corbin KD & Zeisel SH. (2012). Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Current Opinion in Gastroenterology, 28(2), 159–165.
- Mato JM, Martínez-Chantar ML & Lu SC. (2008). Methionine metabolism and liver disease. Annual Review of Nutrition, 28, 273–293.
- Croze ML & Soulage CO. (2013). Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie, 95(10), 1811–1827.
- Longo N, Frigeni M & Pasquali M. (2016). Carnitine transport and fatty acid oxidation. Biochimica et Biophysica Acta, 1863(10), 2422–2435.
Research Disclaimer
This product is intended strictly for laboratory research purposes only. It is not a drug, food, cosmetic, or dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease. It is not for human or animal consumption. All information presented is derived from published scientific literature and is provided for educational reference only. By purchasing, the buyer affirms they are a qualified researcher or institution and assume full responsibility for the safe and lawful handling of this material.